{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:42:45Z","timestamp":1787773365541,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NHS England Genomics Programme"},{"name":"NIHR ARC-GM"},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Biomedical Research Centre"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implement Sci Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Some people experience side-effects from medicines which can lead to negative patient outcomes and increased NHS costs. Pharmacogenetic-guided prescribing supports the safety and effectiveness of medicines. The Pharmacogenetics Roll Out \u2013 Gauging Response to Service (PROGRESS) study is assessing the viability and utility of pharmacogenetic-guided prescribing in general practice. We conducted a parallel process evaluation to explore the barriers and enablers to implementing pharmacogenetic-guided prescribing in general practice, from a clinician perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-nine online semi-structured interviews were conducted with 30 general practice staff across 20 sites in England implementing the PROGRESS study. We used a modified framework approach to analyse the data, informed by the Consolidated Framework for Implementation Research and Normalisation Process Theory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Clinicians saw value in offering pharmacogenetic-guided prescribing in general practice, but limited testing to where they perceived it provided greatest benefit. There was limited evidence of practices planning for implementation beyond setting up the PROGRESS study. Sites tailored delivery of pharmacogenetics to their local practice context, which acted as an enabler to implementation. Delivering pharmacogenetic-guided prescribing within the confines of a research study and clinicians\u2019 workload acted as barriers to implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>General practice staff understood the value and purpose of pharmacogenetic-guided prescribing, but there was little evidence of wider practice involvement beyond raising awareness among staff. PROGRESS involvement was viewed as more as proof of concept for research purposes, rather than normalising pharmacogenetics into routine practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43058-026-01005-x","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:34:31Z","timestamp":1782491671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implementing pharmacogenetic-guided prescribing in general practice: a qualitative process evaluation"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-6557","authenticated-orcid":false,"given":"Lisa","family":"Brunton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-4678","authenticated-orcid":false,"given":"William","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5220-8837","authenticated-orcid":false,"given":"John","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-5780","authenticated-orcid":false,"given":"Paul","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"6","key":"1005_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/pds.3947","volume":"25","author":"F Zhang","year":"2016","unstructured":"Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf. 2016;25(6):628\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1005_CR2","volume-title":"Medicines Optimisation: Helping patients to make the most of medicines Good practice guidance for health professionals in England","author":"Royal Pharmaceutical Society","year":"2013","unstructured":"Royal Pharmaceutical Society. Medicines Optimisation: Helping patients to make the most of medicines Good practice guidance for health professionals in England. London: Royal Pharmaceutical Society; 2013."},{"issue":"7","key":"1005_CR3","doi-asserted-by":"publisher","first-page":"e055551","DOI":"10.1136\/bmjopen-2021-055551","volume":"12","author":"R Osanlou","year":"2022","unstructured":"Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022;12(7):e055551.","journal-title":"BMJ Open"},{"issue":"6","key":"1005_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","volume":"24","author":"M Pirmohamed","year":"2023","unstructured":"Pirmohamed M. Pharmacogenomics: current status and future perspectives. Nat Rev Genet. 2023;24(6):350\u201362.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"1005_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cpt.1651","volume":"107","author":"MV Relling","year":"2020","unstructured":"Relling MV, Klein TE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Caudle KE. The clinical pharmacogenetics implementation consortium: 10 years later. Clin Pharmacol Ther. 2020;107(1):171\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"1005_CR6","unstructured":"NHS England. The NHS Long Term Plan2019 08.04.2025]. Available from: www.longtermplan.nhs.uk\/publication\/nhs-long-term-plan."},{"key":"1005_CR7","volume-title":"2022 to 2025 implementation plan for England","author":"UK Genome","year":"2022","unstructured":"Department of Health & Social Care, Genome UK. 2022 to 2025 implementation plan for England. London: Policy paper; 2022. 13.12.2022."},{"key":"1005_CR8","unstructured":"Department of Health & Social Care. Fit for the Future: 10 year Heath Plan for England.: HMSO. 2025 [01.12.2025]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/6888a0b1a11f859994409147\/fit-for-the-future-10-year-health-plan-for-england.pdf."},{"key":"1005_CR9","unstructured":"Royal College of Physicians and British Pharmacological Sociey. Personalised Prescribing: Using pharmacogenomics to improve patient outcomes. London, UK; 2022."},{"issue":"1","key":"1005_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13012-022-01249-w","volume":"17","author":"M Wensing","year":"2022","unstructured":"Wensing M, Sales A, Aarons GA, Xu DR, Wilson P. Evidence for objects of implementation in healthcare: considerations for Implementation Science and Implementation Science Communications. Implement Sci. 2022;17(1):83.","journal-title":"Implement Sci"},{"issue":"18","key":"1005_CR11","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1001\/jama.2016.3867","volume":"315","author":"DA Chambers","year":"2016","unstructured":"Chambers DA, Feero WG, Khoury MJ. Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research. JAMA. 2016;315(18):1941\u20132.","journal-title":"JAMA"},{"key":"1005_CR12","unstructured":"Study to assess the rollout of a genetic-guided prescribing service in UK General Practice ISRCTN: ISRCTN. 2023 [08.04.2025]. Available from: https:\/\/www.isrctn.com\/ISRCTN15390784."},{"key":"1005_CR13","unstructured":"The Kings Fund. Activity in the NHS. 2024."},{"issue":"12","key":"1005_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2217\/pgs-2021-0032","volume":"22","author":"J Hayward","year":"2021","unstructured":"Hayward J, McDermott J, Qureshi N, Newman W. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models. Pharmacogenomics. 2021;22(12):761\u201376.","journal-title":"Pharmacogenomics"},{"issue":"6","key":"1005_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"1005_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-29","volume":"4","author":"CR May","year":"2009","unstructured":"May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009;4:1\u20139.","journal-title":"Implement Sci"},{"key":"1005_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-016-0506-3","volume":"11","author":"CR May","year":"2016","unstructured":"May CR, Johnson M, Finch T. Implementation, context and complexity. Implement Sci. 2016;11:1\u201312.","journal-title":"Implement Sci"},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:1\u201315.","journal-title":"Implement Sci"},{"issue":"9","key":"1005_CR19","doi-asserted-by":"publisher","first-page":"e044720","DOI":"10.1136\/bmjopen-2020-044720","volume":"11","author":"D Schroeder","year":"2021","unstructured":"Schroeder D, Luig T, Beesoon S, Robert J, Campbell-Scherer D, Brindle M. What work is required to implement and sustain the National Surgical Quality Improvement Program (NSQIP)? A qualitative study of NSQIP implementation in Alberta, Canada. BMJ open. 2021;11(9):e044720.","journal-title":"BMJ open"},{"key":"1005_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-014-0090-3","volume":"9","author":"LA Connell","year":"2014","unstructured":"Connell LA, McMahon NE, Harris JE, Watkins CL, Eng JJ. A formative evaluation of the implementation of an upper limb stroke rehabilitation intervention in clinical practice: a qualitative interview study. Implement Sci. 2014;9:1\u201312.","journal-title":"Implement Sci"},{"key":"1005_CR21","unstructured":"Parker C, Scott S, Geddes A, Atkinson P, Delamont S, Cernat A et al. Snowball Sampling: SAGE Publications Limited; 2020."},{"issue":"2","key":"1005_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/psych4020013","volume":"4","author":"DB Allsop","year":"2022","unstructured":"Allsop DB, Chelladurai JM, Kimball ER, Marks LD, Hendricks JJ. Qualitative Methods with Nvivo Software: A Practical Guide for Analyzing Qualitative Data. Psych. 2022;4(2):142\u201359.","journal-title":"Psych"},{"key":"1005_CR23","doi-asserted-by":"crossref","unstructured":"Green J, Thorogood N. Qualitative methods for health research. 2018.","DOI":"10.4135\/9781036234386"},{"key":"1005_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:1\u20138.","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"1005_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2217\/pgs-2019-0004","volume":"20","author":"M-P Frigon","year":"2019","unstructured":"Frigon M-P, Blackburn M-\u00c8, Dubois-Bouchard C, Gagnon A-L, Tardif S, Tremblay K. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics. 2019;20(8):589\u201398.","journal-title":"Pharmacogenomics"},{"issue":"5","key":"1005_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/pme-2017-0036","volume":"14","author":"AA Lemke","year":"2017","unstructured":"Lemke AA, Hutten Selkirk CG, Glaser NS, Sereika AW, Wake DT, Hulick PJ, Dunnenberger HM. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Personalized Med. 2017;14(5):389\u2013400.","journal-title":"Personalized Med"},{"key":"1005_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm policy mental health mental health Serv Res. 2011;38:65\u201376.","journal-title":"Adm policy mental health mental health Serv Res"},{"key":"1005_CR28","doi-asserted-by":"crossref","unstructured":"Brownson RC, Colditz GA, Proctor EK. Dissemination and Implementation Research in Health: Translating Science to Practice. Oxford University Press; 2017.","DOI":"10.1093\/oso\/9780190683214.001.0001"},{"issue":"7455","key":"1005_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/bmj.328.7455.1561","volume":"328","author":"P Hawe","year":"2004","unstructured":"Hawe P, Shiell A, Riley T. Complex interventions: how out of control can a randomised controlled trial be? BMJ. 2004;328(7455):1561\u20133.","journal-title":"BMJ"},{"issue":"1","key":"1005_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-publhealth-031912-114421","volume":"36","author":"P Hawe","year":"2015","unstructured":"Hawe P. Lessons from complex interventions to improve health. Annu Rev Public Health. 2015;36(1):307\u201323.","journal-title":"Annu Rev Public Health"},{"key":"1005_CR31","volume-title":"Fit for the future: GP pressures 2023","author":"Royal College of General Practitioners","year":"2023","unstructured":"Royal College of General Practitioners. Fit for the future: GP pressures 2023. London: RCGP; 2023."}],"container-title":["Implementation Science Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43058-026-01005-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-026-01005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-026-01005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:34:22Z","timestamp":1786538062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43058-026-01005-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1186\/s43058-026-01005-x","relation":{},"ISSN":["2662-2211"],"issn-type":[{"value":"2662-2211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the University of Manchester proportionate review ethics committee [Ref: 2024-19186-33057, dated 12.02.2024] and the Health Research Authority [Ref: 24\/HRA\/0989, dated 26.03.2024]. Verbal recorded informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PB is Co-Editor-in-Chief of Implementation Science and an Editorial Board member for Implementation Science Communications. WN and JM are co-founders of an early-stage health technology start-up, Fava Health Ltd.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"149"}}